Compounded tirzepatide from PlexusDx's licensed 503A pharmacies contains the same active pharmaceutical ingredient and undergoes the same quality standards as brand-name Mounjaro
Because GLP-1 is a sensitive market term, NuCoreBio recommends confirming final product name, ingredient panel, dosage format, and market claims with the buyers compliance team before launch
Regulatory history: Sermorelin was FDA-approved in 1997 under the brand name Geref for the treatment of growth hormone deficiency in children
2 GLP-1 release also slows gastric emptying, reduces appetite, and decreases food intake, thus making this peptide an attractive target for obesity pharmacologics
Many patients are unaware they have it
Weyer, C., Bogardus, C., Mott, D